Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA AI in Pathology Market, by Neural Network
1.4.2 LAMEA AI in Pathology Market, by Application
1.4.3 LAMEA AI in Pathology Market, by End User
1.4.4 LAMEA AI in Pathology Market, by Component
1.4.5 LAMEA AI in Pathology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 Market Share Analysis, 2022
4.2 Recent Strategies Deployed in AI in Pathology Market
4.3 Porter’s Five Forces Analysis
Chapter 5. LAMEA AI in Pathology Market, By Neural Network
5.1 LAMEA Convolutional neural networks (CNNs) Market, By Country
5.2 LAMEA Generative adversarial networks (GANs) Market, By Country
5.3 LAMEA Recurrent neural networks (RNNs) Market, By Country
5.4 LAMEA Others Market, By Country
Chapter 6. LAMEA AI in Pathology Market, By Application
6.1 LAMEA Drug Discovery Market, By Country
6.2 LAMEA Disease Diagnosis & Prognosis Market, By Country
6.3 LAMEA Clinical Workflow Market, By Country
6.4 LAMEA Others Market, By Country
Chapter 7. LAMEA AI in Pathology Market, By End User
7.1 LAMEA Pharmaceutical & Biotechnology Companies Market, By Country
7.2 LAMEA Hospitals & Reference Laboratories Market, By Country
7.3 LAMEA Academic & Research Institutes Market, By Country
Chapter 8. LAMEA AI in Pathology Market, By Component
8.1 LAMEA Scanners Market, By Country
8.2 LAMEA Software Market, By Country
Chapter 9. LAMEA AI in Pathology Market, By Country
9.1 Brazil AI in Pathology Market
9.1.1 Brazil AI in Pathology Market, By Neural Network
9.1.2 Brazil AI in Pathology Market, By Application
9.1.3 Brazil AI in Pathology Market, By End User
9.1.4 Brazil AI in Pathology Market, By Component
9.2 Argentina AI in Pathology Market
9.2.1 Argentina AI in Pathology Market, By Neural Network
9.2.2 Argentina AI in Pathology Market, By Application
9.2.3 Argentina AI in Pathology Market, By End User
9.2.4 Argentina AI in Pathology Market, By Component
9.3 UAE AI in Pathology Market
9.3.1 UAE AI in Pathology Market, By Neural Network
9.3.2 UAE AI in Pathology Market, By Application
9.3.3 UAE AI in Pathology Market, By End User
9.3.4 UAE AI in Pathology Market, By Component
9.4 Saudi Arabia AI in Pathology Market
9.4.1 Saudi Arabia AI in Pathology Market, By Neural Network
9.4.2 Saudi Arabia AI in Pathology Market, By Application
9.4.3 Saudi Arabia AI in Pathology Market, By End User
9.4.4 Saudi Arabia AI in Pathology Market, By Component
9.5 South Africa AI in Pathology Market
9.5.1 South Africa AI in Pathology Market, By Neural Network
9.5.2 South Africa AI in Pathology Market, By Application
9.5.3 South Africa AI in Pathology Market, By End User
9.5.4 South Africa AI in Pathology Market, By Component
9.6 Nigeria AI in Pathology Market
9.6.1 Nigeria AI in Pathology Market, By Neural Network
9.6.2 Nigeria AI in Pathology Market, By Application
9.6.3 Nigeria AI in Pathology Market, By End User
9.6.4 Nigeria AI in Pathology Market, By Component
9.7 Rest of LAMEA AI in Pathology Market
9.7.1 Rest of LAMEA AI in Pathology Market, By Neural Network
9.7.2 Rest of LAMEA AI in Pathology Market, By Application
9.7.3 Rest of LAMEA AI in Pathology Market, By End User
9.7.4 Rest of LAMEA AI in Pathology Market, By Component
Chapter 10. Company Profiles
10.1 Koninklijke Philips N.V.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 F. Hoffmann-La Roche Ltd.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.6 SWOT Analysis
10.3 Hologic, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Visiopharm A/S
10.4.1 Company Overview
10.4.2 Recent strategies and developments:
10.4.2.1 Partnerships, Collaborations, and Agreements:
10.4.3 SWOT Analysis
10.5 Paige AI, Inc.
10.5.1 Company Overview
10.5.2 Recent strategies and developments:
10.5.2.1 Partnerships, Collaborations, and Agreements:
10.5.2.2 Product Launches and Product Expansions:
10.5.3 SWOT Analysis
10.6 PathAI, Inc.
10.6.1 Company Overview
10.6.2 Recent strategies and developments:
10.6.2.1 Partnerships, Collaborations, and Agreements:
10.6.3 SWOT Analysis
10.7 Aiforia Technologies Plc
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Recent strategies and developments:
10.7.3.1 Partnerships, Collaborations, and Agreements:
10.7.4 SWOT Analysis
10.8 Indica Labs, Inc.
10.8.1 Company Overview
10.8.2 Recent strategies and developments:
10.8.2.1 Partnerships, Collaborations, and Agreements:
10.8.3 SWOT Analysis
10.9 Optrascan, Inc. (Optra Ventures, LLC)
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:
10.9.2.2 Product Launches and Product Expansions:
10.9.3 SWOT Analysis
10.10. MindPeak GmbH
10.10.1 Company Overview
10.10.2 Recent strategies and developments:
10.10.2.1 Partnerships, Collaborations, and Agreements:
10.10.3 SWOT Analysis
Unique Offerings 